Comprehensive screening of multiclass illegal adulterants in herbal supplements and Spice-type drugs using specific MS/MS fragmentations by UHPLC-Q/TOF-MS

Literature Information

Publication Date 2019-09-16
DOI 10.1039/C9AY01517E
Impact Factor 2.896
Authors

Jisu Hur, Wonwoong Lee, Beom Hee Kim, Hyun Ji Kim, Do Hee Lee, Ji Hyun Lee, Yong Moon Lee, Han Bin Oh, Jongki Hong


View Original

Abstract

In this study, a comprehensive screening method for 98 multi-class illegal adulterants (19 NSAIDS, 31 weight loss drugs, 35 psychotropic substances, and 13 cannabinoids) in dietary supplements and Spice drugs was suggested by UHPLC-Q/TOF-MS. After effective application of pH controlled liquid–liquid extraction from herbal supplements and Spice-type drugs, a broad range of 98 adulterants was successfully separated within 15 min on 1.7 μm fused-core C18 particles in a 100 × 2.1 mm column with gradient elution (mobile phase A: 0.1% formic acid in water; B: 0.1% formic acid in acetonitrile) and sensitively detected at sub-ng g−1 levels by ESI in positive ion mode. From the MS/MS spectra of illegal adulterants, certain common ions were observed to reflect their structural characteristics: m/z 117 for phenethylamines, m/z 155 and 144 for synthetic cannabinoids, m/z 165 and 199 for opioid analogues and m/z 125 and 158 for sibutramine analogues. Specific neutral molecule loss fragments were also observed: H2O, NH3, or CO respectively for hydroxyl, amine, or carbonyl group containing adulterants. Phenylamide, C7H4O3S, or C2H3NO molecule loss fragmentations were observed for heterocyclic compounds. Based on these specific fragmentations, extracted common ion chromatograms (ECICs) and neutral loss scans (NLSs) were effectively applied for rapid screening of illegal adulterants in herbal supplements and Spice-type drugs. The developed method can serve as a promising screening tool for confirmation and determination of illegal adulterants in various types of supplements, thus ensuring public safety.

Related Literature

Correlation between gelation time, structure and texture of low-doped silica gels

Elise Berrier, Laurence Courtheoux, Mohamed Bouazaoui, Bruno Capoen, Sylvia Turrell

2010-10-01 Paper

DOI: 10.1039/C0CP01090A

Controlled growth of metallic inverse opals by electrodeposition

Nina Sapoletova, Tatyana Makarevich, Kirill Napolskii, Elena Mishina, Andrey Eliseev, Albert van Etteger, Theo Rasing, Galina Tsirlina

2010-11-02 Paper

DOI: 10.1039/C0CP00812E

Molecular electrocatalysis at soft interfaces

Manuel A. Méndez, Raheleh Partovi-Nia, Imren Hatay, Bin Su, PeiYu Ge, Astrid Olaya, Nathalie Younan, Mohamad Hojeij, Hubert H. Girault

2010-10-01 Perspective

DOI: 10.1039/C0CP00590H

Direct assay of electropermeabilization in a 2D pseudo tissue

2010-10-06 Communication

DOI: 10.1039/C0CP01343A

Decoration of nitrogen vacancies by oxygen atoms in boron nitride nanotubes

Mladen Petravic, Robert Peter, Ivna Kavre, Lu Hua Li, Ying Chen, Liang-Jen Fan, Yaw-Wen Yang

2010-10-22 Communication

DOI: 10.1039/C0CP00984A

Surface-plasmon-assisted electromagnetic wave propagation

Wenbo Yang, Jennifer M. Reed, Haining Wang, Shengli Zou

2010-08-23 Paper

DOI: 10.1039/C0CP00221F

Divalent cations reduce the pH sensitivity of OmpF channel inducing the pKa shift of key acidic residues

María Queralt-Martín, Elena García-Giménez, Salvador Mafé, Antonio Alcaraz

2010-11-03 Paper

DOI: 10.1039/C0CP01325K

Non-IPR fullerenes with properly closed shells

Patrick W. Fowler, Wendy Myrvold

2010-10-08 Paper

DOI: 10.1039/C0CP01513J

You might also like

Compound Q&A

How is Ethyl 4-chlorothieno[2,3-b]pyridine-5-carboxylate (CAS: 59713-58-5) typically synthesized?

Ethyl 4-chlorothieno[2,3-b]pyridine-5-carboxylate (CAS: 59713-58-5) can be synth...

59713-58-5Ethyl 4-chlorothieno...
Compound Q&A

What regulatory guidelines apply to 5-Methyl-1H-indole-3-carbaldehyde (CAS: 52562-50-2)?

5-Methyl-1H-indole-3-carbaldehyde (CAS: 52562-50-2) is subject to various regula...

52562-50-25-Methyl-1H-indole-3...
Compound Q&A

What are the physical and chemical properties of (1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)boronic acid (CAS: 223418-73-3)?

(1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)boronic acid is a white...

223418-73-3(1,3-Dimethyl-2,4-di...
Compound Q&A

How should waste containing Sulfocostunolide A (CAS: 1016983-51-9) be handled?

Waste containing Sulfocostunolide A (CAS: 1016983-51-9) should be handled with c...

1016983-51-9Sulfocostunolide A
Compound Q&A

What precautions should be taken when handling Murraxocin (CAS: 88478-44-8)?

When handling Murraxocin (CAS: 88478-44-8), ensure proper personal protective eq...

88478-44-8Murraxocin
Compound Q&A

What are the physical and chemical properties of Formvar (CAS: 63148-64-1)?

Formvar (CAS: 63148-64-1) is an alkyd resin characterized by a high molecular we...

63148-64-1Formvar(R)
Compound Q&A

Is (S)-4-benzyl-2-((benzyloxy)methyl)morpholine (CAS: 205242-66-6) safe?

(S)-4-benzyl-2-((benzyloxy)methyl)morpholine is generally safe when handled with...

205242-66-6(S)-4-benzyl-2-((ben...
Compound Q&A

What industries use Methyl 1-(5-bromo-2-pyrimidinyl)cyclopropanecarboxylate (CAS: 1447607-69-3)?

Methyl 1-(5-bromo-2-pyrimidinyl)cyclopropanecarboxylate (CAS: 1447607-69-3) is p...

1447607-69-3Methyl 1-(5-bromo-2-...
Compound Q&A

Is 2-Methyl-1-phenyl-1-propanamine hydrochloride (CAS: 24290-47-9) safe?

2-Methyl-1-phenyl-1-propanamine hydrochloride (CAS: 24290-47-9) is generally con...

24290-47-92-Methyl-1-phenyl-1-...
Compound Q&A

How is 3-(4-Bromophenyl)-2-methylpropanoic acid (CAS: 66735-01-1) typically synthesized?

3-(4-Bromophenyl)-2-methylpropanoic acid is synthesized through a multi-step pro...

66735-01-13-(4-Bromophenyl)-2-...

Source Journal

Analytical Methods

Analytical Methods
CiteScore: 5.1
Self-citation Rate: 3.7%
Articles per Year: 655

Analytical Methods welcomes early applications of new analytical and bioanalytical methods and technology demonstrating the potential for societal impact. We require that methods and technology reported in the journal are sufficiently innovative, robust, accurate, and compared to other available methods for the intended application. Developments with interdisciplinary approaches are particularly welcome. Systems should be proven with suitably complex and analytically challenging samples. We encourage developments within, but not limited to, the following technologies and applications: global health, point-of-care and molecular diagnostics biosensors and bioengineering drug development and pharmaceutical analysis applied microfluidics and nanotechnology omics studies, such as proteomics, metabolomics or glycomics environmental, agricultural and food science neuroscience biochemical and clinical analysis forensic analysis industrial process and method development

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.